Tuberculosis Diagnosis Made Easy
Tuberculosis diagnosis usually requires coughing up a sputum sample from the lungs, but another way has been found to identify the disease.
Tuberculosis diagnosis usually requires coughing up a sputum sample from the lungs, but another way has been found to identify the disease.
Researchers have developed a microscopy system for non-invasive conjunctival goblet cells examination in patients.
StatLab provides products and support directly to anatomic pathology and will now partner with Thomas Scientific to distribute its solutions.
Results from the IMPACT trial demonstrate clear patient benefit in using Roche’s CINtec PLUS Cytology dual-stain biomarker technology.
In a demonstration, the technique distinguished between healthy samples and either cancerous or pre-cancerous cells with nearly 100 percent accuracy.
This method of fluorescence microscopy for cell observation circumvents fundamental problems: light-induced destruction and unceasing molecule movement.
Research points to saliva testing as a potential alternative to blood sampling for patients with bipolar disorder, schizophrenia, and depression.
Increased availability of such devices may help to facilitate continuity of patient care by preventing disruptions to critical pathology services.
Researchers have found that a liquid biopsy method using lab-on-a-chip technology can identify biomarkers of concern before a tumor even forms.
The research focuses on a new method to process and immunolabel breast cancer core needle biopsies.